Rani Therapeutics Files Proxy Supplement for May 28 Meeting
Ticker: RANI · Form: DEFA14A · Filed: Apr 30, 2025 · CIK: 1856725
| Field | Detail |
|---|---|
| Company | Rani Therapeutics Holdings, Inc. (RANI) |
| Form Type | DEFA14A |
| Filed Date | Apr 30, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy, shareholder-meeting
Related Tickers: RANI
TL;DR
RANI proxy supplement filed, meeting May 28. Vote your shares!
AI Summary
Rani Therapeutics Holdings, Inc. filed a Definitive Additional Materials proxy statement on April 30, 2025, supplementing its proxy statement for the Annual Meeting of Stockholders scheduled for May 28, 2025. The filing is related to the company's solicitation of proxies for this upcoming meeting.
Why It Matters
This filing provides shareholders with updated information and materials relevant to their voting decisions at the upcoming annual meeting, ensuring they have the necessary details to participate in corporate governance.
Risk Assessment
Risk Level: low — This is a routine proxy filing, providing supplemental information for an upcoming shareholder meeting, and does not inherently introduce new financial or operational risks.
Key Players & Entities
- Rani Therapeutics Holdings, Inc. (company) — Registrant
- May 28, 2025 (date) — Annual Meeting of Stockholders
- April 30, 2025 (date) — Filing Date
FAQ
What type of filing is this?
This is a DEFA14A filing, specifically a supplement to the Definitive Proxy Statement.
Who is the filing company?
The filing company is Rani Therapeutics Holdings, Inc.
When is the Annual Meeting of Stockholders scheduled?
The Annual Meeting of Stockholders is scheduled to be held on May 28, 2025.
What is the purpose of this filing?
This filing serves as a supplement to the definitive proxy statement, providing additional materials for the upcoming annual meeting of stockholders.
What is the filing date of this document?
This document was filed on April 30, 2025.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on April 30, 2025 regarding Rani Therapeutics Holdings, Inc. (RANI).